126 related articles for article (PubMed ID: 20477917)
1. Successful treatment of an acute attack of acquired angioedema with the bradykinin-B2-receptor antagonist icatibant.
Weller K; Magerl M; Maurer M
J Eur Acad Dermatol Venereol; 2011 Jan; 25(1):119-20. PubMed ID: 20477917
[No Abstract] [Full Text] [Related]
2. Successful treatment of hereditary angioedema with bradykinin B2-receptor antagonist icatibant.
Krause K; Metz M; Zuberbier T; Maurer M; Magerl M
J Dtsch Dermatol Ges; 2010 Apr; 8(4):272-4. PubMed ID: 19758369
[TBL] [Abstract][Full Text] [Related]
3. Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant).
Bork K; Frank J; Grundt B; Schlattmann P; Nussberger J; Kreuz W
J Allergy Clin Immunol; 2007 Jun; 119(6):1497-503. PubMed ID: 17418383
[TBL] [Abstract][Full Text] [Related]
4. Bradykinin-receptor antagonist icatibant: possible treatment for ACE inhibitor-related angio-oedema.
Manders K; van Deuren M; Hoedemaekers C; Simon A
Neth J Med; 2012 Oct; 70(8):386-7. PubMed ID: 23065991
[No Abstract] [Full Text] [Related]
5. Icatibant: a novel approach to the treatment of angioedema related to the use of angiotensin-converting enzyme inhibitors.
Gallitelli M; Alzetta M
Am J Emerg Med; 2012 Oct; 30(8):1664.e1-2. PubMed ID: 22100478
[TBL] [Abstract][Full Text] [Related]
6. Treatment of idiopathic nonhistaminergic angioedema with bradykinin B2 receptor antagonist icatibant.
Del Corso I; Puxeddu I; Sardano E; Geraci S; Breggia M; Rocchi V; Migliorini P
Ann Allergy Asthma Immunol; 2012 Jun; 108(6):460-1. PubMed ID: 22626601
[No Abstract] [Full Text] [Related]
7. Bradykinin receptor 2 antagonist (icatibant) for hereditary angioedema type III attacks.
Bouillet L; Boccon-Gibod I; Ponard D; Drouet C; Cesbron JY; Dumestre-Perard C; Monnier N; Lunardi J; Massot C; Gompel A
Ann Allergy Asthma Immunol; 2009 Nov; 103(5):448. PubMed ID: 19927548
[No Abstract] [Full Text] [Related]
8. Icatibant treatment for acquired C1-inhibitor deficiency: a real-world observational study.
Zanichelli A; Bova M; Coerezza A; Petraroli A; Triggiani M; Cicardi M
Allergy; 2012 Aug; 67(8):1074-7. PubMed ID: 22686628
[TBL] [Abstract][Full Text] [Related]
9. Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant.
Bas M; Bier H; Greve J; Kojda G; Hoffmann TK
Allergy; 2006 Dec; 61(12):1490-2. PubMed ID: 17073887
[No Abstract] [Full Text] [Related]
10. Successful treatment of a facial attack of angioedema with icatibant in a patient with idiopathic angioedema.
Montinaro V; Loizzo G; Zito A; Castellano G; Gesualdo L
Am J Emerg Med; 2013 Aug; 31(8):1295.e5-6. PubMed ID: 23706583
[No Abstract] [Full Text] [Related]
11. Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series.
Bas M; Greve J; Stelter K; Bier H; Stark T; Hoffmann TK; Kojda G
Ann Emerg Med; 2010 Sep; 56(3):278-82. PubMed ID: 20447725
[TBL] [Abstract][Full Text] [Related]
12. The role of icatibant-the B2 bradykinin receptor antagonist-in life-threatening laryngeal angioedema in the ED.
Bartal C; Zeldetz V; Stavi V; Barski L
Am J Emerg Med; 2015 Mar; 33(3):479.e1-3. PubMed ID: 25241359
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of ACE inhibitor-induced angioedema with icatibant, a bradykinin B2 receptor antagonist.
Pucar PA; O'Sullivan M; Goudie A; Marr T; Brusch A
Med J Aust; 2015 Jun; 202(11):596-7. PubMed ID: 26068694
[No Abstract] [Full Text] [Related]
14. Treatment of angiotensin-converting enzyme inhibitor-related angioedema with the bradykinin B2 receptor antagonist icatibant.
Schmidt PW; Hirschl MM; Trautinger F
J Am Acad Dermatol; 2010 Nov; 63(5):913-4. PubMed ID: 20554347
[No Abstract] [Full Text] [Related]
15. Successful long-term treatment with the bradykinin B2 receptor antagonist icatibant in a patient with hereditary angioedema.
Greve J; Hoffmann TK; Schuler P; Lang S; Chaker A; Bas M
Int J Dermatol; 2011 Oct; 50(10):1294-5. PubMed ID: 21950301
[TBL] [Abstract][Full Text] [Related]
16. Icatibant , the bradykinin B2 receptor antagonist with target to the interconnected kinin systems.
Charignon D; Späth P; Martin L; Drouet C
Expert Opin Pharmacother; 2012 Oct; 13(15):2233-47. PubMed ID: 22970904
[TBL] [Abstract][Full Text] [Related]
17. Rapid resolution of erythema marginatum after icatibant in acquired angioedema.
Bygum A; Broesby-Olsen S
Acta Derm Venereol; 2011 Mar; 91(2):185-6. PubMed ID: 21279303
[No Abstract] [Full Text] [Related]
18. Treatment of ACEI-related angioedema with icatibant: a case series.
Bova M; Guilarte M; Sala-Cunill A; Borrelli P; Rizzelli GM; Zanichelli A
Intern Emerg Med; 2015 Apr; 10(3):345-50. PubMed ID: 25666515
[TBL] [Abstract][Full Text] [Related]
19. Role of kinins in seasonal allergic rhinitis: icatibant, a bradykinin B2 receptor antagonist, abolishes the hyperresponsiveness and nasal eosinophilia induced by antigen.
Turner P; Dear J; Scadding G; Foreman JC
J Allergy Clin Immunol; 2001 Jan; 107(1):105-13. PubMed ID: 11149999
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial of icatibant in ACE-inhibitor-induced angioedema.
Baş M; Greve J; Stelter K; Havel M; Strassen U; Rotter N; Veit J; Schossow B; Hapfelmeier A; Kehl V; Kojda G; Hoffmann TK
N Engl J Med; 2015 Jan; 372(5):418-25. PubMed ID: 25629740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
